DOW JONES25,409.36-357.28 -1.39%
S&P 5002,954.22-24.54 -0.82%
NASDAQ8,567.37+0.89 0.01%

Wells Fargo Maintains Overweight on Abbott Laboratories, Raises Price Target to $103

Wells Fargo maintains Abbott Laboratories (NYSE:ABT) with a Overweight and raises the price target from $97 to $103.

Benzinga · 01/23/2020 13:33

Wells Fargo maintains Abbott Laboratories (NYSE:ABT) with a Overweight and raises the price target from $97 to $103.